Live Breaking News & Updates on Medical science mumbai

Stay informed with the latest breaking news from Medical science mumbai on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Medical science mumbai and stay connected to the pulse of your community

Chemed (NYSE:CHE) Lowered to "Hold" at StockNews.com

Chemed (NYSE:CHE – Get Free Report) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report issued on Friday. Several other research firms have also issued reports on CHE. Royal Bank of Canada upped their price target on shares of Chemed from $604.00 to $712.00 and gave […]

Canada , United-states , Sugarloaf , Nova-scotia , Louisiana , Spencers-lee , Brianc-judkins , Raymond-james-associates , Raymond-james-financial-services-advisors-inc , Sugarloaf-wealth-management , Chemed-corporation

Quad area Wednesday COVID-19 briefing: 1 Carson City death, 7 new cases, 26 recoveries

Carson City Health and Human Services is reporting Wednesday, August 5, 2020 that there is an additional death due to COVID-19 in the Quad-County region. The individual was a Carson City resident in his 50’s. There are also seven new cases and 26 additional recoveries of COVID-19 in the Quad-County region.

Lyon-county , Nevada , United-states , Carson-city , Storey-county , Douglas-county , Carson-city-health , Nevada-health-response , Human-services , City-health , 2020

Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXTW) Short Interest Update

Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXTW – Get Free Report) was the recipient of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 500 shares, an increase of 150.0% from the March 31st total of 200 shares. Based on an average trading volume of 3,000 […]

Nasdaq , Lixte-biotechnology-holdings-inc , Lixte-biotechnology-company-profile , Lixte-biotechnology-holdings , Get-free-report , Biotechnology-holdings , Lixte-biotechnology-daily , Lixte-biotechnology , Nasdaq-lixtw , Lixtw , Medical

Vext Science (OTCMKTS:VEXTF) Trading 3.3% Higher

Vext Science, Inc. (OTCMKTS:VEXTF – Get Free Report)’s stock price shot up 3.3% during mid-day trading on Wednesday . The stock traded as high as C$0.18 and last traded at C$0.18. 15,856 shares traded hands during mid-day trading, a decline of 52% from the average session volume of 33,378 shares. The stock had previously closed […]

United-states , Vext-science-company-profile , Vext-science-inc , Vext-science , Get-free-report , Vext-science-daily , Otcmkts-vextf , Vextf , Medical , Stocks , Technicals

VBI Vaccines Inc. (NASDAQ:VBIV) Short Interest Up 145.4% in April

VBI Vaccines Inc. (NASDAQ:VBIV – Get Free Report) was the recipient of a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 709,500 shares, a growth of 145.4% from the March 31st total of 289,100 shares. Based on an average daily volume of 445,600 shares, […]

Vaccines-inc , Vbi-vaccines-inc , Nasdaq , Get-free-report , Trading-down , Vbi-vaccines , Nasdaq-vbiv , Vbiv , Medical , Stocks , Options

Short Interest in Revelation Biosciences, Inc. (NASDAQ:REVB) Declines By 43.6%

Revelation Biosciences, Inc. (NASDAQ:REVB – Get Free Report) was the target of a significant decrease in short interest in the month of April. As of April 15th, there was short interest totalling 18,500 shares, a decrease of 43.6% from the March 31st total of 32,800 shares. Based on an average daily volume of 391,900 shares, […]

Exchange-commission , Sabby-management , Revelation-biosciences-inc , Nasdaq , Revelation-biosciences , Get-free-report , Free-report , Revelation-biosciences-daily , Nasdaq-revb , Revb , Medical

UnitedHealth Group Incorporated (NYSE:UNH) Stake Increased by Spinnaker Trust

Spinnaker Trust increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 3.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,397 shares of the healthcare conglomerate’s stock after acquiring an additional 495 shares during the period. […]

United-states , America , Erin-mcsweeney , Thomase-roos , Unitedhealth-group , Quarter-for-unitedhealth-group , Rise-advisors , Morgan-stanley , Unitedhealth-group-stock-performance , Great-valley-advisor-group-inc , News-ratings-for-unitedhealth-group-daily , Unitedhealth-group-announces-dividend

Integer (NYSE:ITGR) Issues FY 2024 Earnings Guidance

Integer (NYSE:ITGR – Get Free Report) updated its FY 2024 earnings guidance on Thursday. The company provided EPS guidance of 5.010-5.430 for the period, compared to the consensus EPS estimate of 5.310. The company issued revenue guidance of $1.7 billion-$1.8 billion, compared to the consensus revenue estimate of $1.8 billion. Integer also updated its FY24 […]

United-states , Costa-rica , Puerto-rico , America , Keycorp , Integer-holdings-corporation , Integer-company-profile , Get-free-report , Moderate-buy , Holdings-corporation , Integer-daily

Cartesian Therapeutics' (RNAC) Outperform Rating Reiterated at Leerink Partnrs

Leerink Partnrs reiterated their outperform rating on shares of Cartesian Therapeutics (NASDAQ:RNAC – Free Report) in a research note released on Tuesday, Zacks.com reports. Leerink Partnrs also issued estimates for Cartesian Therapeutics’ Q1 2024 earnings at ($1.34) EPS, Q2 2024 earnings at ($1.38) EPS, Q3 2024 earnings at ($1.27) EPS, Q4 2024 earnings at ($1.09) […]

Hall-laurie , Timothya-springer , Leerink-partnrs , Nasdaq , Exchange-commission , Needham-company , Securities-exchange-commission , Cartesian-therapeutics-company-profile , Cartesian-therapeutics-inc , Cartesian-therapeutics , Free-report , Get-free-report

Medpace (NASDAQ:MEDP) Raised to Buy at Jefferies Financial Group

Jefferies Financial Group upgraded shares of Medpace (NASDAQ:MEDP – Free Report) from a hold rating to a buy rating in a report issued on Tuesday morning, MarketBeat Ratings reports. The brokerage currently has $450.00 price target on the stock, up from their previous price target of $340.00. A number of other equities analysts have also […]

United-states , America , Robertw-baird , Susane-burwig , Rise-advisors , Jefferies-financial-group , Mather-group , Riverpark-advisors , Fintrust-capital-advisors , Medpace-investors-llc , Deutsche-bank-aktiengesellschaft